Skip to main content

Matthew V. Soran

  • Partner | M&A and Private Equity

New York

T: +1.212.859.8462

Headshot of Matthew V. Soran

Matthew Soran is a partner in the Corporate Department and the M&A and Private Equity Practice, resident in New York.

Matthew has significant experience in mergers and acquisitions, having represented private investment groups and public and private companies in mergers, stock and asset acquisitions and divestitures, carveout transactions, joint ventures, recapitalizations, growth equity investments, venture investments, secondary sales of private equity limited partnership interests, and other corporate and governance matters.

Work highlights:

  • CVS Health in its pending acquisition of Signify Health, and its sales of Coventry Workers Comp Services, PayFlex Holdings, and bswift.
  • Catalent, in numerous engagements, including its US$1.2b acquisition of Paragon Bioservices, its US$950 million acquisition of Cook Pharmica, its US$315m acquisition of MaSTherCell Global, and its acquisitions of Accucaps Industries Limited, Pharmapak Technologies, Micron Technologies, and Redwood Bioscience
  • ...

Matthew Soran is a partner in the Corporate Department and the M&A and Private Equity Practice, resident in New York.

Matthew has significant experience in mergers and acquisitions, having represented private investment groups and public and private companies in mergers, stock and asset acquisitions and divestitures, carveout transactions, joint ventures, recapitalizations, growth equity investments, venture investments, secondary sales of private equity limited partnership interests, and other corporate and governance matters.

Work highlights:

  • CVS Health in its pending acquisition of Signify Health, and its sales of Coventry Workers Comp Services, PayFlex Holdings, and bswift.
  • Catalent, in numerous engagements, including its US$1.2b acquisition of Paragon Bioservices, its US$950 million acquisition of Cook Pharmica, its US$315m acquisition of MaSTherCell Global, and its acquisitions of Accucaps Industries Limited, Pharmapak Technologies, Micron Technologies, and Redwood Bioscience
  • Goldman Sachs Asset Management in numerous engagements, including its acquisition of Standard & Poor's Investment Advisory Services and its acquisition of Rocaton Investment Advisors.
  • Thomson Reuters in its acquisition of Clarient Global and Avox Limited from DTCC and a bank shareholder consortium.

Matthew consistently engages with some of the premier thought leaders in the industry through participation in panels and speaking opportunities for Transaction Advisors and the Loan Syndication and Trading Association, among others. Matthew is also involved with both diversity and inclusion and pro bono efforts. Within Fried Frank, Matthew previously served on the Firmwide Diversity Committee. In 2016, The Leadership Council on Legal Diversity selected him as a Fellow. Matthew regularly works on pro bono engagements with Volunteer Lawyers for the Arts (VLA) and Start Small Think Big.

Matthew is recognized by Legal 500 in M&A: Large Deals ($1 billion+) with client sources calling him “top notch” and “extremely responsive, deeply knowledgeable about M&A and…creative in addressing problems.” The publication has also listed him as a “Next Generation Lawyer” since 2017, in recognition of his M&A experience. A frequent speaker and writer, he recently participated in events for the National Association of Corporate Directors (NACD) and Thomson Reuters covering topics such as shareholder activism, M&A, and private equity trends. He has co-authored articles published in various publications including Law360, The M&A Lawyer, Harvard Law School Forum on Corporate Governance and Financial Regulation. Most recently, Matthew was named a 2022 BTI Consulting Client Service All-Star. 

Professional associations

  • Member, Mergers, Acquisitions & Corporate Control Contests Committee, New York City Bar Association

News and recognition

Insights and analysis

Alerts and newsletters |

M&A/PE Quarterly Newsletter, Winter 2022

Alerts and newsletters |

M&A/PE Quarterly, Fall 2022

Events

Speaking engagements |

Transaction Advisors’ M&A Strategy Forum

Speaking engagements |

Harvard Corporate Governance Roundtable 

Speaking engagements |

Transactions Advisors M&A Conference

Speaking engagements |

NACD Master Class

Speaking engagements |

M&A Conference at Fordham Law in New York
Back to top